HomeZVSA • OTCMKTS
add
Zyversa Therapeutics Inc
Previous close
$0.19
Day range
$0.19 - $0.23
Year range
$0.11 - $1.67
Market cap
1.62M USD
Avg Volume
18.37K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 551.86K | -57.11% |
Net income | -678.57K | 52.27% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -550.12K | 57.24% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 101.78K | -93.35% |
Total assets | 347.90K | -98.31% |
Total liabilities | 12.73M | 5.39% |
Total equity | -12.39M | — |
Shares outstanding | 8.10M | — |
Price to book | -0.12 | — |
Return on assets | -198.77% | — |
Return on capital | 11.44% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -678.57K | 52.27% |
Cash from operations | -413.69K | 65.94% |
Cash from investing | — | — |
Cash from financing | -12.51K | -100.48% |
Net change in cash | -426.20K | -130.27% |
Free cash flow | -162.69K | 83.01% |
About
Founded
2014
Headquarters
Website
Employees
6
